We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

1 hedge funds and large institutions have $19K invested in ENZON PHARMACEUTICALS INC in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $16K → $19K (+$3K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$3.01K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$19K +$3.01K +12,218 +19%

ENZN Hedge Fund Activity: Q4 2018 in Review

1 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q4 2018, worth a combined $19K — up 19% from $16K a quarter earlier.

Fund positioning in ENZN was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Panagora Asset Management, adding an estimated $3.01K.

  • 1 institutional investor held ENZON PHARMACEUTICALS INC (ENZN) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $19K of ENZON PHARMACEUTICALS INC stock for Q4 2018, up 19% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q4 2018 and 0 closed out.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q4 2018 was Panagora Asset Management, an estimated $3.01K added.

Based on aggregated 13F filings for Q4 2018.